Exciting Announcement: Cerneos Group and Chronon Bio LTD have officially solidified their partnership with the signing of a Memorandum of Understanding (MOU) for a strategic collaboration in early biologic drug discovery. Together, they will jointly market and deliver services, with the goal of establishing a comprehensive preclinical research alliance.
This collaboration between Cerneos Group (USA) and Chronon Bio LTD (UK) involves the mutual promotion of their services to expedite the development of high-quality biologic drugs. Chronon Bio will provide commercial services in preclinical research, while Cerneos Group will leverage its expertise in Global Regulatory Affairs, Clinical Affairs, and Scientific consulting.
We are thrilled about the potential of this partnership and look forward to propelling advancements in early biologic drug discovery. Stay tuned for updates as we embark on this exciting journey together!
For more information, visit:
https://www.chronon.bio
https://cerneos.com
#Biotech #DrugDiscovery #Partnership #Innovation #Collaboration